Bvf Inc Mersana Therapeutics, Inc. Transaction History

Bvf Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.24 - $23.4 $12.4 Million - $55.5 Million	-2,372,400 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $5.26 Million - $11.1 Million	1,191,847 Added 100.96%	2,372,400 $13.8 Million
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $4.15 Million - $19.3 Million	-2,861,335 Reduced 70.79%	1,180,553 $6.77 Million
Q3 2019 Nov 14, 2019	BUY	$1.54 - $4.2 $2.38 Million - $6.48 Million	1,543,988 Added 61.81%	4,041,888 $6.39 Million
Q2 2019 Aug 14, 2019	SELL	$3.84 - $6.4 $8,064 - $13,440	-2,100 Reduced 0.08%	2,497,900 $10.1 Million
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $8.78 Million - $18.3 Million	2,500,000 New	2,500,000 $13.2 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $201M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.